¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"species area curve"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accidental species
    ¿ì¿¬Á¾
  • species
    Á¾
  • species control
    Á¾°ü¸®
  • species name
    Á¾¸í
  • species nova
    ½ÅÁ¾
  • species specificity
    Á¾Æ¯À̼º
  • species-specific
    Á¾Æ¯ÀÌ-
  • species-specific antigen
    Á¾Æ¯ÀÌÇ׿ø
  • species-specific reactivity
    Á¾Æ¯À̹ÝÀÀ¼º
  • articulation curve
    ¾ð¾î¸í·áµµ°î¼±
  • audiometric curve
    û·Â°î¼±
  • auditory sensation curve
    °¡Ã»°î¼±, û°¢°î¼±
  • air conduction curve
    °ø±âÀüµµÃ»·Â°î¼±
  • base curve
    ±âº»°î¼±
  • bimodal curve
    µÎ²À´ë±â°î¼±, ÀÌÁ¤Á¡°î¼±
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • species name
    Á¾¸í
  • species
    Á¾
  • species nova
    ½ÅÁ¾
  • species specificity
    Á¾Æ¯À̼º
  • curve
    °î¼±
  • epidemic curve
    À¯Çà°î¼±
  • learning curve
    ÇнÀ°î¼±
  • regression curve
    ȸ±Í°î¼±
  • response curve
    ¹ÝÀÀ°î¼±
  • survival curve
    »ýÁ¸°î¼±
  • area
    ±¸¿ª, ¿µ¿ª, ¿ª, ºÎÀ§, ºÎ, ¸éÀû
  • area cribrosa
    ü±¸¿ª
  • area postrema
    ¸Ç¾Æ·¡±¸¿ª
  • inguinal area
    »ô±¼ºÎÀ§, ¼­ÇýºÎ
  • preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accidental species
    ¿ì¿¬Á¾
  • allopatric species
    °Ý¸®Áö¿ªÁ¾
  • bacterial species
    ¼¼±ÕÁ¾
  • coelozoic species
    ¸ö°ø°£±â»ýÁ¾, ü°­±â»ýÁ¾
  • cytozoic species
    ¼¼Æ÷³»±â»ýÁ¾
  • species control
    Á¾°ü¸®
  • digenetic species
    º¹¼¼´ëÁ¾, À̼¼´ëÁ¾
  • dominant species
    ¿ì¼ºÁ¾
  • elementary species
    ±âº»Á¾
  • free living species
    ÀÚÀ¯»ýȰÁ¾
  • histozoic species
    Á¶Á÷±â»ýÁ¾
  • monogenetic species
    ´Ü»ýÁ¾, ´Ü¼¼´ëÁ¾
  • mutant species
    µ¹¿¬º¯ÀÌÁ¾
  • species name
    Á¾¸í
  • polyploidy species
    ´Ù¹è¼öÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • AUC : area under the concentration-time curve
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • area under the concentration-time curve : AUC
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • Kluyvera species
    Ŭ·çÀ§º£¶óÁ¾
  • Species
    Á¾ (ºÐ·ùÇÐÀÇ)
  • antigen, species-specific
    Á¾Æ¯ÀÌÇ׿ø
  • aromaticae species
    ¹æÇâ´ÙÁ¦(¡­ó±ð¥).
  • polyploidy species
    ´Ù¹è¼öÁ¾(ÒýÛÃâ¦ðú).
  • Hemoglobin-oxygen equilibrium curve
    Çì¸ð±Û·Îºó-»ê¼Ò°î¼±
  • Length/tension curve
    ±æÀÌ/Àå·Â(íåÕô) °î¼±(ÍØàÊ)
  • frenquency response curve
    Á֯ļö ¹ÝÀÀ°î¼±
  • frequency curve
    µµ¼ö°î¼±(̬ËàË­ËÛ).
  • frequency curve
    µµ¼ö°î¼±
  • frequency distribution curve
    µµ¼öºÐÆ÷°î¼±.
  • frequency distribution curve
    µµ¼öºÐÆ÷°î¼±
  • glow curve
    ¹é¿­°î¼±
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • area under the concentration-time curve : AUC
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • cochlear area, =area cochleae <³ª>
    ¿Í¿ì¿µ¿ª, ´ÞÆØÀ̽Ű汸¿ª{ÇØ}
  • cochlear area<³ª> area cochleae
    ´ÞÆØÀ̽Ű汸¿ª, ¿Í¿ì¾ß(èÄéÚå¯).
  • supplemental motor area = supplementary area
    º¸Á¶¿îµ¿¿µ¿ª(ÜÍð¾ê¡ÔÑçÐæ´)
  • antigen, species-specific
    Á¾Æ¯ÀÌÇ׿ø
  • aromaticae species
    ¹æÇâ´ÙÁ¦(¡­ó±ð¥).
  • bacterial species
    ¼¼±ÕÁ¾
  • cosmopolitan species
    (¼¼°è)º¸ÆíÁ¾(ÊÙÌ¡).
  • cytozoic species
    ¼¼Æ÷³»±â»ýÁ¾(¡­Ò®Ðößæðú).
  • digenetic species
    À̼¼´ëÁ¾(ì£á¦ÓÛðú).
  • dominant species
    ¿ì¼ºÁ¾.
  • dominant species
    ¿ì¼ºÁ¾(éÐàõðú).
  • elementary species
    ±âº»Á¾(ÐñÜâðú).
  • introduced species
    ¿Ü·¡Á¾(ËíËÄÌ¡).
  • monogenetic species
    ´Ü¼¼´ëÁ¾(Ó¤á¦ÓÛðú).»ý¸®´Ü¼º»ý½ÄÁ¾, ºÎ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Marginal area
    °¡ÀåÀÚ¸®±¸¿ª
    [¿¾ ¿ë¾î] º¯¿¬ºÎ
  • Cupula area
    ²À´ë±â±¸¿ª
    [¿¾ ¿ë¾î] ¹èºÎ
  • Subcallosal area
    ³úµéº¸¹Ø±¸¿ª
    [¿¾ ¿ë¾î] ¾çÇϾß
  • Cochlear area
    ´ÞÆØÀ̽Ű汸¿ª
    [¿¾ ¿ë¾î] ¿Í¿ì¾ß
  • Contact area
    ´ê´ÂºÎºÐ
    [¿¾ ¿ë¾î] Á¢Ã˸é
  • Posterior intercondylar area
    µÚÀ¶±â»çÀ̱¸¿ª
    [¿¾ ¿ë¾î] Èİú°£±¸
  • Area postrema
    ¸Ç¾Æ·¡±¸¿ª
    [¿¾ ¿ë¾î] ÃÖÇϾß
  • Bare area
    ¹«À帷±¸¿ª
    [¿¾ ¿ë¾î] ¹«À帷¾ß
  • Opaque area
    ºÒÅõ¸í±¸¿ª
    [¿¾ ¿ë¾î] ¾Ï¾ß[ºÎ]
  • Vesiclular area
    ¼ÒÆ÷±¸¿ª
    [¿¾ ¿ë¾î] ¼ÒÆ÷ºÎ
  • Preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
    [¿¾ ¿ë¾î] ½Ã½Å°æ±³Â÷Àü¾ß
  • Cardiogenic area
    ½ÉÀå¹ß»ý±¸¿ª
    [¿¾ ¿ë¾î] ½ÉÀå¹ß»ý±¸¿ª
  • Inferior vestibular area
    ¾Æ·¡¾È¶ã½Å°æ±¸¿ª
    [¿¾ ¿ë¾î] ÇÏÀüÁ¤¾ß
  • Vestibular area
    ¾È¶ã±¸¿ª
    [¿¾ ¿ë¾î] ÀüÁ¤½Å°æ¾ß
  • Anterior intercondylar area
    ¾ÕÀ¶±â»çÀ̱¸¿ª
    [¿¾ ¿ë¾î] Àü°ú°£±¸
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperendemic area
    °íµµÀ¯ÇàÁö
  • hypoendemic area
    ÀúµµÀ¯ÇàÁö
  • allopatric species
    ÀÌÁö¿ªÁ¾
  • cytozoic species
    ¼¼Æ÷³»±â»ýÁ¾
  • free living species
    ÀÚÀ¯»ýȰÁ¾
  • histozoic species
    Á¶Á÷±â»ýÁ¾
  • species specificity
    Á¾Æ¯À̼º
  • vector species
    ¸Å°³Á¾
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • economic species
    °æÁ¦Á¾(Ìèð­ðú)
  • enzyme species
    È¿¼ÒÁ¾(ý£áÈðú)
  • calibration curve
    "°ËÁ¤°î¼±(ËþïÒÍØàÊ), Ç¥Áذ(øöñÞÍØàÊ)"
  • Cot curve
    Cot °î¼±(ÍØàÊ)
  • dose-response curve
    ¿ë·®´ëÀÀ °î¼±(é»ÕáÓßëëÍØàÊ)
  • error curve
    ¿ÀÂ÷ °î¼± (è¦ó¬ÍØàÊ)
  • exponential curve
    Áö¼ö °î¼± (ò¦â¦ÍØàÊ)
  • exponential survival curve
    Áö¼ö »ýÁ¸ °î¼± (ò¦â¦ßæðíÍØàÊ)
  • fall curve
    °¨¼Ò °î¼± (Êõá´ÍØàÊ)
  • Gaussian error curve
    °¡¿ì½º ¿ÀÂ÷ °î¼±(è¦ó¬ ÍØàÊ)
  • gradient curve
    ±¸¹è °î¼±(ÎþÛÕÍØàÊ)
  • growth curve
    ¼ºÀå°î¼± (à÷íþÍØàÊ)
  • hydrogen ion titration curve
    ¼ö¼Ò(â©áÈ)À̿ ÀûÁ¤°î¼±(îêïÒÍØàÊ)
  • melting curve
    À¶Çذ(ë×ú°ÍØàÊ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • curve
    °î¼±
  • dissociation curve
    ÇØ¸®°î¼±
  • elastic curve
    ź¼º°î¼±
  • exponential curve
    Áö¼ö°î¼±
  • fluid velocity curve
    À¯¼Ó°î¼±
  • growth curve
    Áõ½Ä°î¼±, ¼ºÀå°î¼±
  • isodose curve
    µî¼±·®°î¼±
  • phase curve
    À§»ó°î¼±
  • time compensation curve
    ½Ã°£º¸»ó°î¼±
  • time gain compenstaion curve
    ½Ã°£°ÔÀκ¸»ó°î¼±
  • time motion curve
    ½Ã°£¿îµ¿°î¼±
  • adjacent area
    ÀÎÁ¢¿ª
  • area
    ¿µ¿ª, ¾ß, Áö¿ª, ±¸
  • bare area
    ³ëÃâºÎ
  • Broca's area
    ºê·ÎÄ«¿µ¿ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
nov sp new species [Lat. novum species]
FTC Federal Trade Commission; follicular thyroid carcinoma; frequency threshold curve; frequency tuning ...
AUC area under the curve
IRS immunoreactive secretion; infrared spectrophotometry; insulin receptor species; insulin receptor sub...
ROS reactive oxygen species; review of systems; rod outer segment
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AUC Area Under Curve
AUC Area Under the Curve
AUC Area under concentration-time curve
AUC Area under the concentration curve
AUC Area-under-the-response-curve
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • area under the concentration-time curve
    Ç÷Áß ³óµµ °î¼±ÇÏ ¸éÀû, Ç÷Áß ¾à¹° ³óµµ °î¼±ÇÏ ¸éÀû
  • aromaticae species
    ¹æÇâ´ÙÁ¦
  • monogenetic species
    ´Ü ¼¼´ëÁ¾
  • mutant species
    µ¹¿¬º¯ÀÌÁ¾
  • pseudomonas species
    ½´¸ð¸ð³ª½ºÁ¾, ºñÀú±ÕÁ¾
  • species
    Á¾, Á¾Á·, ´ÙÁ¦
    1. ¼Ó ¶Ç´Â ¾Æ¼ÓÀÇ ÇÏÀ§À̰í, ¾ÆÁ¾ ¶Ç´Â º¯Á¾ÀÇ »óÀ§ÀÎ ºÐ·ùÇлó ¹üÁַμ­, ±¸º°µÇ´Â °øÅëÀÇ Æ¯Â¡À» °¡Áø °³Ã¼·Î ÀÌ·ç¾îÁø´Ù. ºÐ·ùÇлó ¸í¸í¹ý¿¡ À־ s
  • angular spectrum envelope curve
    ?
  • anodic polarization curve
    ¾ç±Ø Æí±¤ °î¼±, ¾ç±Ø ºÐ±Ø °î¼±
  • anteroposterior curve
    ÀüÈÄ ¸¸°î
  • auditory sensation curve
    °¡Ã» °î¼±
  • Barnes' curve
    ¹Ù¾È½º °î¼±
    õ°ñ°©°¢À» Áß½ÉÀ¸·Î ÇÏ´Â °î¼±.
  • calibration curve
    º¸Á¤ °î¼±, Ç¥ÁØÈ­ °î¼±
  • carbon dioxide dissociation curve
    ź»ê °¡½º ÇØ¸® °î¼±
  • cell survival curve
    ¼¼Æ÷ »ýÁ¸ °î¼±
  • compensating curve
    Á¶Àý ¸¸°î
    »ó¾Ç Ä¡¿­¿¡ À־ ¼Ò±¸Ä¡ ´ë±¸Ä¡ÀÇ ÇùÃø ±³µÎ¸éÀ» ¿¬°áÇϸé, ¾Æ·¡·Î º¼·ÏÇÑ °î¼±À» ±×¸®°í ÀÖ´Ù. ÀÌ ¸¸°î¿¡ ÀÇÇÏ¿© ÇϾÇÀÇ Ãø¹æ ¿îµ¿ ½Ã¿¡ °úµÎ°¡ ÀüÇϹæÀ¸·Î ¿îµ¿ÇÏ´õ¶óµµ »óÇÏ Ä¡¾ÆÀÇ ±ÕÇü Á¢ÃËÀº À¯ÁöµÇµµ·Ï Á¶ÀýµÈ´Ù. °¡·É »óÇÏÀÇ Ä¡¾Æ°¡ Æò¸é»ó¿¡ ¹è¿­Çß´Ù°í ÇÑ´Ù¸é, Ãø¹æ ¿îµ¿¿¡ ÀÇÇÏ¿© °úµÎ´Â »ç¸é¿¡ µû¶ó ÀüÇϹæÀ¸·Î À̵¿ÇϹǷÎ, ´ë±¸Ä¡ ¹× ¼Ò±¸Ä¡¿¡¼­ »óÇÏ Ä¡¾Æ »çÀÌ¿¡ Æ´ÀÌ »ý±ä´Ù. À̰ÍÀ» ÆòźÇÑ Ä¡¾ÆÀÇ ¿îµ¿°ú ºñ½ºµëÇÑ ±³µÎÀÇ ¿îµ¿¸é°úÀÇ »çÀÌ¿¡ ºÒ±ÕÇüÀÌ »ý±â±â ¶§¹®ÀÌ´Ù. ±×·¯¹Ç·Î ¸¸°î¸é »ó¿¡ Ä¡¾Æ¸¦ ¹è¿­ÇÑ´Ù. ÀÌ ¿ë¾î´Â ÀÇÄ¡¿¡ ÇÑÇÏ¿© »ç¿ëµÇ´Â °æ¿ì°¡ ¸¹´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
species area curve The curve on a graph produced when plotting the cumulative number of plant species found in a series of quadrats against the cumulative number or area of those quadrats, it is used to determine the number of quadrats sufficient to adequately survey the herbaceous understory.
(09 Oct 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
area under curve A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the auc from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies.
(12 Dec 1998)
area under the curve A measure of how much of a drug reaches the bloodstream in a set period of time, usually 24 hours. AUC is calculated by plotting drug blood concentration at various times during a 24-hour or longer period and then measuring the area under the curve between 0 and 24 hours as shown in the figure to the right.
(09 Oct 1997)
candidate species <ecology> Any species or subspecies of bird, mammal, fish, amphibian, reptile, or plant that is being considered for listing as endangered or threatened but is not yet the subject of a proposed rule.
(16 Dec 1997)
management indicator species A species whose habitat requirements most reflect those of the species community in the habitat of concern, usually used to indicate habitat quality and to predict future conditions.
(09 Oct 1997)
rare species A species of animal or plant that is considered rare, threatened, or endangered.
(17 Dec 1997)
reactive oxygen species Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development.
(12 Dec 1998)
mid seral species Shade intolerant species, primarily Douglas-fir trees and vine maple shrubs. These species typically follow the early seral species in natural succession.
(05 Dec 1998)
sensitive species <ecology, zoology> Species that can only survive within a narrow range of environmental conditions and whose disappearance from an area is an index of pollution or other environmental change.
Those species which rely on specific habitat conditions that are limited in abundance, restricted in distribution, or are particularly sensitive to development.
Plant or animal species which are endangered species, or candidate species, protected bird species under endangered species laws and regulations, plant protection laws and regulations, Fish and Game codes, or species of special concern listings and policies, or species recognised by national, state, or local environmental organisations.
(18 Nov 1997)
species A taxonomic category subordinate to a genus (or subgenus) and superior to a subspecies or variety, composed of individuals possessing common characters distinguishing them from other categories of individuals of the same taxonomic level. In taxonomic nomenclature, species are designated by the genus name followed by a Latin or Latinised adjective or noun.
(18 Nov 1997)
species group <zoology> The taxonomic categories species and subspecies.
(09 Jan 1998)
species indeterminata <zoology> Undetermined species, one not identifiable with the description for a name already published. Usually given with a generic name only.
(09 Jan 1998)
species inquirendum <zoology> A species to be queried, a doubtfully identified species requiring further investigation.
(09 Jan 1998)
species-specific Applying only to a particular species, said of effects that vary depending on the species in question.
(09 Oct 1997)
species-specific antigen Antigenic components in the tissues and fluids of members of a species of animal, by means of which various species may be immunologically distinguished; e.g., serum albumin of horses is immunologically different from that of man, dogs, sheep, and so on.
(05 Mar 2000)
species specificity Restriction of a characteristic or response to the members of one species; it usually refers to that property of the immune response which differentiates one species from another on the basis of antigen recognition, but the concept is not limited to immunology and is used loosely at levels higher than the species.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • species
    Á¾,Á¾·ù
  • endangered species
    ¸êÁ¾ À§±â¿¡ óÇÑ µ¿½Ä¹°ÀÇ Á¾
  • species
    Á¾;Á¾·ù;»§°ú Æ÷µµÁÖ
  • curve
    ±¸ºÎ¸®´Ù
  • French curve
    ¿îÇüÀÚ
  • characteristic curve
    Ư¼º °î¼±
  • curve
    °î¼±;(¿©ÀÚÀÇ ¸ö.µµ·Î µîÀÇ)¸¸°îºÎ;±¼°î;(¿©ÀÚÀÇ)°î¼±¹Ì;±¸ºÎ··ÀÌ;°î¼±ÀÚ;°î¼± µµÇ¥;±×·¡ÇÁ;°î¼±;Ä¿ºê(°ø);Ä¿ºê Æò°¡;»ó´ë Æò°¡;±ÁÈ÷´Ù;¸¸°î½ÃŰ´Ù;(°øÀ»)Ä¿ºê½ÃŰ´Ù;±¸ºÎ·¯Áö´Ù;¸¸°îÇÏ´Ù;°î¼±À» ±×¸®´Ù
  • curve killer
    ¿ìµî»ý
  • distribution curve
    (Åë°è)ºÐÆ÷ °î¼±
  • hanging curve
    Çà°Å Ä¿ºê(±¸ºÎ·¯ÁöÁö ¾ÊÀº Ä¿ºê·Î,¶§¸®±â ÁÁÀº °øÀÌ µÊ)
  • howgozit curve
    (ƯÈ÷ ´ë¾çȾ´Ü Ç×°øÁßÀÇ)»óȲ ÆÇ´Ü °î¼±
  • indifference curve
    (°æ) ¹«Â÷º°°î¼±
  • phillips curve
    Çʸ³½ºÄ¿ºê;ÀÎÇ÷¹¿Í ½Ç¾÷·ùÀÇ »ó°ü °ü°è¸¦ ³ªÅ¸³¿
  • response curve
    (¸¶ÀÌÅ©·ÎÆùµîÀÇ)ÀÀ´ä °î¼±
  • area
    ¸éÀû,Áö¿ª
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á